SUBSCRIBE
SUBSCRIBE

Patient recruitment

A female doctor of mixed race, meets with a senior couple as she reviews recent test results with them. The senior couple of African decent, listens closely as they receive the good news.
IN PARTNERSHIP WITH TAKEDA
Takeda’s Commitment to Trial Representation is Shaping the Future of Clinical Research
One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical trials. Two employees from its research and development organization discuss why representation matters and the work their team is doing to benefit patients now and in the future.
January 5, 2026
 · 
5 min read
 · 
BioSpace Insights
Podcast
M&A Ticks Up, ASCO Excites and Vaccines Cause More Drama
Sanofi and BMS paid big money for rare disease and cancer assets, while Regeneron got in the obesity game; AstraZeneca, Gilead and Amgen shone at ASCO; RFK Jr. and the CDC appeared to disagree over COVID-19 vaccine recommendations and several news outlets are questioning the validity of the White House’s Make America Healthy Again report.
June 4, 2025
 · 
2 min read
 · 
Heather McKenzie
PRESS RELEASES
Press Releases
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
November 4, 2025
 · 
4 min read
Press Releases
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
November 4, 2025
 · 
4 min read
Press Releases
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes
November 4, 2025
 · 
5 min read
Press Releases
Forward Therapeutics Announces First Participants Dosed in Phase 1 Healthy Volunteer Study of FT2109, a Next-Generation TNF Signaling Inhibitor
October 31, 2025
 · 
2 min read
Press Releases
Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating GTX-102 in Additional Angelman Syndrome Genotypes and Age Groups
October 31, 2025
 · 
8 min read
Press Releases
Avance Clinical Launches Renal and Cardiometabolic Center of Excellence to Optimize Patient Recruitment to Elevate Study Success
October 31, 2025
 · 
3 min read
Press Releases
Forlong Dosed First Patient in Phase 2 Clinical Trial of FL115, a novel interleukin-15 (IL-15) superagonist, for nonmuscle invasive bladder cancer (NMIBC)
October 31, 2025
 · 
3 min read
Press Releases
InnoCare Announces First Patient Dosed in Clinical Trial of Novel ADC ICP-B794 in China
October 31, 2025
 · 
2 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards
October 29, 2025
 · 
4 min read
Press Releases
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
October 29, 2025
 · 
5 min read
Press Releases
ONL Therapeutics Announces Randomization of First Patient in Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD
October 28, 2025
 · 
4 min read
Press Releases
Biomea Fusion Announces First Patient Dosed in Phase I Study of BMF-650 a Next-Generation Oral GLP-1 Receptor Agonist
October 28, 2025
 · 
6 min read
Press Releases
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
October 28, 2025
 · 
11 min read
Press Releases
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
October 27, 2025
 · 
5 min read
Press Releases
CuraSen Therapeutics Doses First Patient with CuraAX (CST-3056) in Phase 2a Neurogenic Orthostatic Hypotension (nOH) Study
October 24, 2025
 · 
3 min read
Press Releases
Abalos Therapeutics Doses First Patient in Phase 1 Study Evaluating ABX-001 for the Treatment of Solid Tumors
October 23, 2025
 · 
3 min read
Press Releases
Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix’s Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital
October 23, 2025
 · 
15 min read
Press Releases
Electra Therapeutics Announces First Patients Dosed in the SURPASS Phase 2/3 Pivotal Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
October 23, 2025
 · 
4 min read
Press Releases
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
October 23, 2025
 · 
6 min read
Press Releases
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
October 23, 2025
 · 
9 min read
Load More